Quinidine Sulfate is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1962 and has 2 investigational indications. Its therapeutic use is listed as antiarrhythmics and cardiovascular. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Quinicardine and Quinora. Its PubChem CID is 656862.
Quinidine sulfate dihydrate
| CAS No | 6591-63-5 |
|---|---|
| Molecular Formula | C40H54N4O10S |
| Molecular Weight | 782.9 g/mol |
| Synonyms | bis((S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol);sulfuric acid;dihydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Quinidine Sulfate is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1962 and has 2 investigational indications.
The listed CAS number is 6591-63-5.
The listed molecular formula is C40H54N4O10S.
The listed molecular weight is 782.9 g/mol.
bis((S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol);sulfuric acid;dihydrate.
The source lists Quinicardine and Quinora.